Abstract
Chronic hepatitis may progress to cirrhosis and hepatocellular carcinoma (HCC). HCC represents one of the most common human cancers. Incidence rates for this tumor vary widely on a worldwide, suggesting that environmental factors such as infectious microorganisms, carcinogens, or nutrition play a role in its pathogenesis. Several Helicobacter spp. colonize the liver of animals and induce hepatitis. The aim of this study was to determine whether Helicobacter infection was associated with HCV-related liver diseases in humans. Liver tissue samples, including biopsy and surgically excised tissues, were collected from patients positive for hepatitis C viruses (HCV) RNA in the serum. Genomic DNA was extracted from sections of formalin-fixed paraffin-embedded tissues by using the QIAamp Tissue Kit and subjected to polymerase chain reaction (PCR) analysis using two sets of Helicobacter-specific 16S ribosomal RNA primers. To identify positive samples for H. pylori, a set of primers specific for a conserved region in the H. pylori vacA gene were also used. The patients' H. pylori status was determined by ELISA. Forty-one patients (mean age 54.9, range 19–78 years; 24 men) were studied. Thirty patients had chronic viral hepatitis (CH) without (N = 18) or with (N = 12) cirrhosis (CIR), and 11 patients had HCC. Anti-H. pylori IgG was detected in 54%. The expected 422- and 210-bp fragments of Helicobacter 16S rRNA were amplified from 27% of liver samples, including 17% of CH-CIR and 55% of HCC (P = 0.004). The vacA sequence was amplified in 10 of 41(24%) samples (27% of those with HCC).: These data confirm the presence of H. pylori DNA sequences in human liver and suggest an association of Helicobacter spp. with HCV-related chronic liver diseases. Further studies are needed to ascertain whether Helicobacter spp. infection plays a role in the development of HCC.
Similar content being viewed by others
REFERENCES
Munoz N, Bosch X: Epidemiology of hepatocellular carcinoma. In Neoplasms of the liver. K Okuda, Ishak KG (eds)., Tokyo, Springer, 1989, p:3
Yu MW, Chen CJ: Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 17:71–91, 1994
Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326–1333, 1993
Yu SZ: Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 10:674–682, 1995
Colombo M: Hepatitis C virus and hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 13:519–528, 1999
Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G: Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112:463–472, 1997
Zaman SN, Johnson PJ, Williams R: Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas. Cancer 65:1607–1610, 1990
The liver Study group of Japan: Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277, 1990
Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Megraud F: Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89:1431–1439, 2000
Nilsson HO, Mulchandani R, Tranberg KG, Wadstrom T: Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120:323–324, 2001
Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, Roa I: Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:755–763, 1998
Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L: Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemarker? Med Hypotheses 54:275–277, 2000
Fan XG, Zou YY, Wu AH, Li TG, Hu GL, Zhang Z: Seroprevalence of Helicobacter pylori infection in patients with hepatitis B. Br J Biomed Sci 55:176–178, 1998
Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, et al: Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222–1227, 1994
Fox JG, Drolet R, Higgins R, Messier S, Yan L, Coleman BE, Paster BJ, Dewhirst FE: Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34:2479–2482, 1996
Stanley J, Linton D, Burnens AP, Dewhirst FE, On SL, Porter A, Owen RJ, Costas M: Helicobacter pullorum sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 140:3441–3449, 1994
Ward JM, Anver MR, Haines DC, Benveniste RE: Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145:959–968, 1994
Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, Hayward A, Belcher JC, Mendes EN: Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 33:445–454, 1995
Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L: High prevalence of Helicobacter pylori in liver cirrhosis. Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 42:2024–2030, 1997
Sepulveda AR, Santos AC, Yamaoka Y, Wu L, Gutierrez O, Kim JG, Graham DY: Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol 94:3034–3038, 1999
Evans DJ, Evans DG, Graham DY, Klein PD: A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 96:1004–1008, 1989
Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY: Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 3:241–253, 1998
Dore MP, Piana A, Carta M, Atzei A, Are BM, Mura I, Massarelli G, Maida A, Sepulveda AR, Graham DY, Realdi G: Amoxicillin resistance is one reason for failure of amoxicillin omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 12:635–639, 1998
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513–1520, 1994
Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417, 1995
Realdi G, Dore MP, Fastame L: Extragastric manifestations of H. pylori infection: Fact or fiction. Dig Dis Sci 44:229–236, 1999
Yoshida N, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Anderson DC, Wolf RE, Kvietys PR: Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 105:1431–1440, 1993
Crabtree J: Cytokine responses to Helicobacter pylori-induced infection. In E.O. Riecken, M Zeittz, A Stallmach, W Heise (eds). Malignancy and Chronic Inflammation in the Gastrointestinal Tract: New Concepts. Lancaster, Kluwer Academic Publishers, 1995, pp 25–36
Shirai M, Arichi T, Nakazawa T, et al. Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection. J Infection Dis 177:72–80, 1998
Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park HD, Chen GC, Chen G, Yu SZ: Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 17:1317–1321, 1996
Fox JG, Chien CC, Dewhirst FE, Paster BJ, Shen Z, Melito PL, Woodward DL, Rodgers FG: Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen. J Clin Microbiol 38:2546–2549, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dore, M.P., Realdi, G., Mura, D. et al. Helicobacter Infection in Patients with HCV-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma. Dig Dis Sci 47, 1638–1643 (2002). https://doi.org/10.1023/A:1015848009444
Issue Date:
DOI: https://doi.org/10.1023/A:1015848009444